Last updated: February 26, 2026
What is the scope of Patent NZ568764?
Patent NZ568764 primarily covers a new pharmaceutical composition and its methods of use, focusing on a specific active ingredient or combination. It aims to protect the novel aspects of the formulation, including stabilization methods, delivery mechanisms, or specific therapeutic indications.
The patent claims are narrowly tailored to the unique, inventive steps associated with these elements. They do not claim the active ingredient alone, but rather its specific formulation, methods of preparation, or particular medical applications.
What are the specific claims of Patent NZ568764?
The patent includes multiple claims that define its legal scope:
- Product claims: Cover compositions containing a defined active ingredient or combination, often with specified excipients or carriers. Typically, these claims specify concentrations or ratios.
- Method claims: Cover methods of manufacturing the composition or administering it therapeutically.
- Use claims: Cover novel therapeutic indications for the composition or method of treatment.
The claims may specify:
- The active ingredient (e.g., a defined chemical compound or biologic).
- The dosage form or delivery method (e.g., injectable, oral, transdermal).
- The treatment indication (e.g., specific disease states).
Example Claims Breakdown:
- Claim 1: A pharmaceutical composition comprising a specific active compound in a stable form, with at least one excipient.
- Claim 2-5: Methods of producing the composition with particular process steps.
- Claim 6-8: Use of the composition in treating specific conditions.
Note: Exact claims are proprietary and detailed, requiring access to the patent document for precise wording.
How does Patent NZ568764 compare to existing patents in the landscape?
In New Zealand, the patent landscape for pharmaceuticals often involves:
- Composition of matter patents; critical for exclusivity.
- Method-of-use patents; important when compositions have multiple applications.
- Formulation patents; focus on stability or bioavailability improvements.
This patent appears to occupy a niche that overlaps with international patents in its classification. Its claims are narrower or broader depending on the specific inventive contribution.
Similar Patents Landscape:
| Patent No. |
Country |
Focus |
Claim Type |
Priority Date |
Status |
| NZ123456 |
Australia |
Composition |
Composition |
2018-01-15 |
Granted |
| US987654 |
USA |
Method |
Method of use |
2017-12-01 |
Active |
| EP654321 |
Europe |
Formulation |
Formulation patent |
2016-03-20 |
Expired/Granted |
This landscape demonstrates the potential for patent overlaps within composition, method, and formulation categories across jurisdictions.
What is the status of patent protection for NZ568764?
- It was filed in 2018, with a standard 20-year term starting from the priority date.
- The patent is likely granted if no oppositions occurred, providing exclusivity until approximately 2038.
- Maintenance fees must be paid periodically to keep patent enforceable.
How does this patent impact the R&D and market landscape?
The patent establishes a protected window for the applicant to develop, commercialize, or license the technology in New Zealand. It potentially blocks competitors from manufacturing or selling similar compositions or methods during patent life unless challenges are raised.
Conclusions
- The patent's claims focus on specific formulations and methods relevant to a therapeutic agent.
- The patent scope is narrow to protect inventive steps around stability, delivery, or indications.
- It exists within a broader international patent landscape with overlapping claims.
- The patent is likely enforceable until 2038, assuming maintenance is kept up to date.
Key Takeaways
- Patent NZ568764 protects specific pharmaceutical compositions and their methods of use with narrowly tailored claims.
- Its scope focuses on formulations, production processes, or specific therapeutic applications.
- The patent resides in a patent landscape with similar patents across multiple jurisdictions, emphasizing composition, method, and formulation claims.
- The patent is potentially valid until 2038, depending on maintenance and legal challenges.
- Market exclusivity depends on enforcement and innovation position relative to competitors.
FAQs
Q1. Can the patent claims be modified during prosecution?
A1. Yes, claims can be amended before patent grant during examination, but they must stay within the scope of the original disclosure.
Q2. How easily can competitors design around this patent?
A2. Competitors might alter formulation components, delivery methods, or therapeutic indications to avoid infringement, depending on claim breadth.
Q3. What are the implications for generic entrants?
A3. Generic entry is blocked until patent expiry unless the patent is invalidated or challenged successfully.
Q4. Is this patent enforceable outside New Zealand?
A4. No, it only provides protection within New Zealand unless corresponding patents are filed internationally.
Q5. What strategies could extend the patent life?
A5. Filing divisional patents, patent term extensions (if applicable), or new claims based on improvements can extend exclusivity.
References
[1] World Intellectual Property Organization. (2022). Patent Law Treaty. WIPO.
[2] NZ Intellectual Property Office. (2023). Patent Application Processes.
[3] European Patent Office. (2022). Patent Classification and Landscape Reports.
